Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...

Trial shows GRI-0621 improved lung function with signs of fibrosis resolution GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic ...

Financing led by DreamCIS will accelerate and expand development of the company's industry-leading integrated platform, combining human iPSC-derived cells, advanced biosystems, and functional data ...

Small Cap Annovis Bio Inc. (NYSE: ANVS) stock is trading higher on Monday, with a session volume of 12.29 million compared to the average volume of 615.12 thousand as per data from Benzinga Pro. A ...

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...

AI platform to support biomarker-guided therapy development in MASH Mursla Bio has announced a new collaboration with a leading global pharmaceutical company to support biomarker-guided drug ...

When applying for a job, your resume is often the first impression an employer gets. A simple resume format is the most professional and widely accepted choice because it is clean, easy to read, and ...

Company preparing to initiate first-in-human Phase 1 study of CRMA-1001 in early 2026 nChroma Bio, a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the ...

As scientific disinformation skyrockets, the Biotechnology Innovation Organization (BIO)—the world’s largest biotech trade association—is aiming to set the record straight on vaccines, rolling out a ...